Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Lung disease study aims to uncover hidden muscle weakness

NCT ID NCT07249567

First seen Jan 05, 2026 · Last updated Jun 19, 2026 · Updated 22 times

Summary

This study looks at how muscle strength, exercise ability, and oxygen use differ among people with COPD, a pre-COPD condition called PRISm, and healthy adults. Researchers will measure breathing and limb muscle strength, endurance, and oxygen levels in 60 volunteers over age 40. The goal is to better understand these conditions and potentially improve future care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Karabuk University, Physiotherapy and Rehabilitation Application and Research Center

    RECRUITING

    Karabük, Turkey (Türkiye)

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help doctors better understand and manage breathing and muscle problems in people with early-stage lung conditions like PRISm.

What could go wrong

This is an observational study, not a treatment trial. It will not test any new drug or therapy, so it cannot directly improve health outcomes.

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease COPD, severe early onset

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.